A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis



Status:Archived
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2009
End Date:November 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Pharmacodynamics Of CP-690,550, Administered Orally Twice Daily (BID) For 4 Weeks, In Subjects With Active Rheumatoid Arthritis


To explore the effect of CP-690,550 on blood and synovial markers in subjects with
rheumatoid arthritis. To evaluate the safety, tolerability and efficacy of CP-690,550.



We found this trial at
7
sites
Maine Research Associates
Auburn, Maine 04210
2615
mi
from 91732
Auburn, ME
Click here to add this to my saved trials
Pfizer Investigational Site
Akron, Ohio 44314
2038
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Pfizer Investigational Site
Alabaster, Alabama 35007
1788
mi
from 91732
Alabaster, AL
Click here to add this to my saved trials
Pfizer Investigational Site
Baltimore, Maryland 21234
2305
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Pfizer Investigational Site
Houston, Texas 77030
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Pfizer Investigational Site
Los Angeles, California 90027
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Pfizer Investigational Site
Seattle, Washington 98166
951
mi
from 91732
Seattle, WA
Click here to add this to my saved trials